ASX Share rice
Tue 04 Aug 2020 - 03:30:pm (Sydney)

IBX Share Price


IBX Company Information


Imagion Biosystems Limited




Diagnostics & Research


10355 Science Center Drive San Diego CA United States 92121


855 564 5264

Pres & CEO:

Mr. Robert Romeo Proulx

Company Sec. & Non Exec. Director:

Ms. Jovanka Naumoska

Vice-Pres of Research & Pre- Clinical Dev:

Dr. Marie Zhang

Company Overview:

Imagion Biosystems Limited provides medical imaging technologies to detect and eliminate cancer. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company engages in the research and development of its MagSense system to detect HER2 breast cancers. It uses MagSense technology that is based on superparamagnetic relaxometry for early cancer detection, cancer staging, and therapeutic monitoring. The company was founded in 1996 and is based in San Diego, California.

IBX Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


IBX CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


IBX Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Interest Expense:


Total Revenue:


Total Operating Expenses:


IBX Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


IBX Share Price History

IBX News

13 Nov, 2019
MELBOURNE, Australia, Nov. 12, 2019 /PRNewswire/ -- Imagion Biosystems Limited (IBX.AX), a company dedicated to improving healthcare through the earlier detection of cancer, has been issued patent #320872 from the Government of India Patent Office for the Company's core intellectual property related to detection, measurement and imaging using targeted magnetic nanoparticles. The newly issued patent adds India to the Company's existing global market coverage which includes Australia, Canada, China, Israel, Japan, Russia, and the U.S. The term of the India patent extends to 2030. The number of people receiving a diagnosis of cancer in India is expected to increase from 1.15 million in 2018 to 1.41 million by 2026, according to the International Agency for Research on Cancer.
30 Oct, 2019
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
16 Oct, 2019
MELBOURNE, Australia, Oct. 16, 2019 /PRNewswire/ -- Imagion Biosystems Limited (IBX.AX) (the Company), a company dedicated to improving healthcare through the earlier detection of cancer, today announces appointments to its newly established Scientific Advisory Board. Chaired by Dr John Hazle, Chair of the Department of Imaging Physics at the MD Anderson Cancer Center and previously a non-executive Director of IBX until June 2019, the Scientific Advisory Board brings together a group of highly qualified experts in disciplines ranging from oncology, medical imaging, nanotechnology and clinical trial design.
24 Sep, 2019
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although
05 Aug, 2019
If you're interested in Imagion Biosystems Limited (ASX:IBX), then you might want to consider its beta (a measure of...